UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April, 2008
Evotec
Aktiengesellschaft
(Exact name of registrant as specified in its charter)
Commission File Number: 001-34041
Evotec AG
Schnackenburgallee 114
22525 Hamburg
Germany
(49-40) 56-0810
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ¨
DOCUMENTS FURNISHED AS PART OF THIS FORM 6-K
See the Exhibit Index to this Form 6-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
Evotec AG | ||
By: | /s/ Klaus Maleck | |
Klaus Maleck | ||
Chief Financial Officer |
Date: May 2, 2008
EXHIBIT INDEX
Exhibit Number | Description | |
99.1 | Press Release dated May 2, 2008. |
Exhibit 99.1
News Release
| May 2, 2008
Evotec Completes Acquisition of Renovis
Hamburg, Germany and South San Francisco, CA – May 2, 2008 – Evotec AG (Frankfurt Stock
In exchange for each outstanding share of Renovis common stock, Renovis stockholders receive 0.5271
Each Evotec ADS represents two ordinary shares of Evotec. As a result, Evotec is issuing an aggregate of
Lehman Brothers Inc. served as the financial advisor to Evotec. Mintz, Levin, Cohn, Ferris, Glovsky and
About Evotec AG Evotec is a leader in the discovery and development of novel small molecule drugs. Both through its own |
News Release
Forward-Looking Statements
Information set forth in this press release contains forward-looking statements, which involve a number of |